We are live on ! Find out more
PA

Perceptive Advisors Portfolio holdings

AUM $6.66B
1-Year Est. Return 360.84%
This Fund
S&P 500
This Quarter Est. Return
+10.27%
1 Year Est. Return
+360.84%
3 Year Est. Return
+1,707.27%
5 Year Est. Return
+3,210.42%
10 Year Est. Return
+53,055.89%
AUM
$1.02B
AUM Growth
+$67.6M
Cap. Flow
+$92.8M
Cap. Flow %
9.11%
Top 10 Hldgs %
47.33%
Holding
173
New
45
Increased
25
Reduced
30
Closed
56

Top Buys

Rank Stock Value
1
QCOR
QUESTCOR PHARMA INC
QCOR
+$31.8M
2
FOLD
Amicus Therapeutics
FOLD
+$26.7M
3
ZBH icon
Zimmer Biomet
ZBH
+$24.4M
4
TARO
Taro Pharmaceutical Industries Ltd.
TARO
+$22.7M
5
INSM icon
Insmed
INSM
+$21.6M

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$17.8M
2
TSRO
TESARO, Inc.
TSRO
+$15.8M
3
EXAS
Exact Sciences
EXAS
+$12.7M
4
ECYT
Endocyte, Inc. Common Stock
ECYT
+$10.4M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$10.1M

Sector Composition

Rank Sector Weight
1 Healthcare 82.29%
2 Miscellaneous 14.83%
3 Consumer Staples 1.81%
4 Financials 1.05%
5 Consumer Discretionary 0.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVDL
26
DELISTED
Avadel Pharmaceuticals
AVDL
$12M 1.18%
800,000
– –
HCA icon
27
HCA Healthcare
HCA
$91.8B
$11.2M 1.09%
197,806
+47,806
+32% +$2.52M
PRTA icon
28
Prothena Corp
PRTA
$428M
$10.9M 1.07%
483,162
+133,162
+38% +$3.33M
AET
29
DELISTED
Aetna Inc
AET
$10.6M 1.04%
+131,308
New +$9.94M
XLRN
30
DELISTED
Acceleron Pharma
XLRN
$10.2M 1%
+300,000
New +$10M
MGNX icon
31
MacroGenics
MGNX
$257M
$9.38M 0.92%
431,803
-17,142
-4% -$360K
ANAC
32
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$9.38M 0.92%
528,776
-118,239
-18% -$1.9M
ITMN
33
DELISTED
INTERMUNE INC
ITMN
$9.27M 0.91%
210,000
-50,000
-19% -$1.84M
ARAV
34
DELISTED
Aravive, Inc. Common Stock
ARAV
$8.86M 0.87%
52,633
-30,911
-37% -$5.34M
RCPT
35
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$8.73M 0.86%
205,000
+170,000
+486% +$5.87M
AGN
36
DELISTED
Allergan Inc
AGN
$8.46M 0.83%
+50,000
New +$7.78M
BDSI
37
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$8.45M 0.83%
700,000
+510,000
+268% +$4.84M
MDT icon
38
Medtronic
MDT
$120B
$8.29M 0.81%
+130,000
New +$7.9M
ASXC
39
DELISTED
Asensus Surgical, Inc.
ASXC
$6.55M 0.64%
+100,000
New +$5.77M
ARWR icon
40
Arrowhead Research
ARWR
$9.98B
$6.04M 0.59%
422,406
+105,106
+33% +$1.38M
TBRA
41
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$5.84M 0.57%
+95,556
New +$5.81M
SPNC
42
DELISTED
Spectranetics Corp
SPNC
$5.57M 0.55%
243,354
-89,200
-27% -$2.07M
ICPT
43
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$4.73M 0.46%
+20,000
New +$5.27M
DSCI
44
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$4.7M 0.46%
406,437
-126,363
-24% -$1.3M
CNC icon
45
Centene
CNC
$33.4B
$4.54M 0.45%
240,000
+229,560
+2,199% +$3.94M
TRVN
46
DELISTED
Trevena, Inc.
TRVN
$4.35M 0.43%
1,232
– –
AERI
47
DELISTED
Aerie Pharmaceuticals
AERI
$4.2M 0.41%
1,121,951
+910,433
+430% +$15.8M
CPRX
48
DELISTED
Catalyst Pharmaceutical
CPRX
$3.79M 0.37%
+1,500,000
New +$3.2M
WBA
49
CALL
DELISTED
Walgreens Boots Alliance
WBA
$3.71M 0.36%
+50,000
New +$3.49M
AGTC
50
DELISTED
Applied Genetic Technologies Corporation
AGTC
$3.4M 0.33%
+146,978
New +$2.59M
1
2
3 4 5

Similar funds

QP
Quilter Plc London, United Kingdom $6.65B AUM 37.83% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
AWA
Arkadios Wealth Advisors Atlanta, Georgia $6.6B AUM 30.67% 1-Year Est. Return
WHRC
W.H. Reaves & Co Jersey City, New Jersey $6.59B AUM 31.9% 1-Year Est. Return
KGA
K5 Global Advisor Miami Beach, Florida $6.59B AUM
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return
CAG
Crestwood Advisors Group Boston, Massachusetts $6.74B AUM 30.22% 1-Year Est. Return

Perceptive Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, Perceptive Advisors held 173 positions worth $1.02B, up 7.1% from $952M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Perceptive Advisors deployed $92.8M of net new capital in Q2 2014, opening 45 new positions and adding to 25 existing holdings. Its largest new stake was Zimmer Biomet: 249,775 shares worth $25.2M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 81% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $17.8M trimmed.

  • Perceptive Advisors's largest Q2 2014 buy was Zimmer Biomet: 249,775 shares worth $25.2M.
  • Perceptive Advisors added most to QUESTCOR PHARMA INC in Q2 2014, an estimated $31.8M increase.
  • Perceptive Advisors's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $17.8M.
  • Perceptive Advisors fully exited Endocyte, Inc. Common Stock in Q2 2014, selling an estimated $10.4M.
  • Perceptive Advisors's ten largest holdings make up 47% of its $1.02B portfolio in Q2 2014.
  • Perceptive Advisors opened 45 new positions and closed 56 in Q2 2014.
  • Perceptive Advisors's portfolio value rose 7.1% quarter-over-quarter to $1.02B.

Based on Perceptive Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.